Xennovate Medical
announces its new EverLift
RemovEZE technology
dramatically reducing, if not eliminating, pain due to
removal of hydrocolloid medical
adhesives.
New adhesive technology reduces the force required to remove medical adhesives such as hydrocolloid dressings from the skin by over 30%, thus minimizing the risk of pain. Repeated applications of medical adhesives on sensitive skin can cause discomfort and skin damage. Xennovate's EverLift™ RemovEZE™ technology
delivers “skin
friendly” benefits such as virtually pain free
removal. With a new easy-to-grasp “tab,”
wound healing and ostomy pouch attachments can now be
secure and comfortable with an easy-to-use and safer
removal.
Dr. David Smith, Xennovate's founder, comments, “We are proud to introduce this exciting new technology for the benefit of patients with severe wounds and ostomy products users everywhere. Ostomy products manufacturers and marketers have demonstrated an enthusiastic response to our thinner, integrated hydrocolloids and combined with our integrated hydrocolloid, xm18, our customers now have a truly innovative and skin safe alternative for better management of wounds and ostomy skin surfaces.
“Moist wound care has become the standard for treatment of most wounds,” according to a study published in Dermatological Surgery in
1995. The same
journal article indicated, “Occlusive dressings
increase re-epithelialization rates by up to 50% and
increase collagen synthesis by up to 60%.” Today it
is generally accepted by clinicians that integrated
hydrocolloids inherently create an acidic, warm, and
airtight wound environment that heal wounds faster than
non-occlusive dressings. Now with EverLift, we have virtually eliminated the
risks of damaging new skin upon removal of the
dressings.
New adhesive technology reduces the force required to remove medical adhesives such as hydrocolloid dressings from the skin by over 30%, thus minimizing the risk of pain. Repeated applications of medical adhesives on sensitive skin can cause discomfort and skin damage. Xennovate's EverLift™ RemovEZE™ technology
Dr. David Smith, Xennovate's founder, comments, “We are proud to introduce this exciting new technology for the benefit of patients with severe wounds and ostomy products users everywhere. Ostomy products manufacturers and marketers have demonstrated an enthusiastic response to our thinner, integrated hydrocolloids and combined with our integrated hydrocolloid, xm18, our customers now have a truly innovative and skin safe alternative for better management of wounds and ostomy skin surfaces.
“Moist wound care has become the standard for treatment of most wounds,” according to a study published in Dermatological Surgery in